Alginate hydrogel improves anti-angiogenic bevacizumab activity in cancer therapy

[Display omitted] Anti-vascular endothelial growth factor (anti-VEGF) therapy applied to solid tumors is a promising strategy, yet, the challenge to deliver these agents at high drug concentrations together with the maintenance of therapeutic doses locally, at the tumor site, minimizes its benefits....

Ausführliche Beschreibung